BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 7892260)

  • 1. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fgf-8, activated by proviral insertion, cooperates with the Wnt-1 transgene in murine mammary tumorigenesis.
    MacArthur CA; Shankar DB; Shackleford GM
    J Virol; 1995 Apr; 69(4):2501-7. PubMed ID: 7884899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.
    Morris DW; Dutra JC
    Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
    Sarkar NH
    Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice.
    Lane TF; Leder P
    Oncogene; 1997 Oct; 15(18):2133-44. PubMed ID: 9393971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice.
    Kwan H; Pecenka V; Tsukamoto A; Parslow TG; Guzman R; Lin TP; Muller WJ; Lee FS; Leder P; Varmus HE
    Mol Cell Biol; 1992 Jan; 12(1):147-54. PubMed ID: 1530875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of both Wnt-1 and Fgf-3 by insertion of mouse mammary tumor virus downstream in the reverse orientation: a reappraisal of the enhancer insertion model.
    Clausse N; Baines D; Moore R; Brookes S; Dickson C; Peters G
    Virology; 1993 May; 194(1):157-65. PubMed ID: 8386870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
    Kapoun AM; Shackleford GM
    Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertional mutagenesis in mouse mammary tumorigenesis.
    Nusse R
    Curr Top Microbiol Immunol; 1991; 171():43-65. PubMed ID: 1667629
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of parity, tumor latency and transplantation on the activation of int loci in MMTV-induced, transplanted C3H mammary pre-neoplasias and their tumors.
    Schwartz MS; Smith GH; Medina D
    Int J Cancer; 1992 Jul; 51(5):805-11. PubMed ID: 1351886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
    Hollmann CA; Kittrell FS; Medina D; Butel JS
    Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis.
    Gallahan D; Jhappan C; Robinson G; Hennighausen L; Sharp R; Kordon E; Callahan R; Merlino G; Smith GH
    Cancer Res; 1996 Apr; 56(8):1775-85. PubMed ID: 8620493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu.
    Elson A; Leder P
    J Biol Chem; 1995 Nov; 270(44):26116-22. PubMed ID: 7592814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse mammary tumor virus sequences responsible for activating cellular oncogenes.
    Grimm SL; Nordeen SK
    J Virol; 1998 Dec; 72(12):9428-35. PubMed ID: 9811675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Int-2, an autocrine and/or ultra-short-range effector in transgenic mammary tissue transplants.
    Ornitz DM; Cardiff RD; Kuo A; Leder P
    J Natl Cancer Inst; 1992 Jun; 84(11):887-92. PubMed ID: 1317463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of int-2: a member of the fibroblast growth factor family.
    Dickson C; Acland P; Smith R; Dixon M; Deed R; MacAllan D; Walther W; Fuller-Pace F; Kiefer P; Peters G
    J Cell Sci Suppl; 1990; 13():87-96. PubMed ID: 1964688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mouse homolog of the hst/k-FGF gene is adjacent to int-2 and is activated by proviral insertion in some virally induced mammary tumors.
    Peters G; Brookes S; Smith R; Placzek M; Dickson C
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5678-82. PubMed ID: 2548184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.